Archives
-
Live-Dead Cell Staining Kit for Hydrogel Assays
2026-09-30
Use dual fluorescence to separate membrane-intact from membrane-compromised cells in biomaterials, cytotoxicity, and osteoclast-related workflows. This practical guide connects Calcein-AM Propidium Iodide staining with the matrix metalloproteinase-responsive hydrogel strategy reported for fibrous dysplasia.
-
Metoprolol for Mechanistic Research Workflows
2026-09-30
Metoprolol enables controlled beta1-receptor perturbation across cardiovascular, inflammatory, cancer, and angiogenesis assays. This practical guide combines reproducible handling steps with pharmacokinetic lessons from a recent MASH study to improve assay design, interpretation, and troubleshooting.
-
MG-132 (Z-LLL-al): Mechanism and Research Use
2026-09-29
MG-132 (Z-LLL-al) is a membrane-permeable peptide aldehyde that inhibits proteasomal proteolysis and can promote protein accumulation, oxidative stress, cell-cycle disruption, and apoptosis. This article separates supplier-reported benchmarks from evidence on autophagy regulation and provides practical controls for apoptosis assay, cell cycle arrest studies, and cancer research.
-
Chlorambucil Assay Workflows for DNA Damage
2026-09-29
Chlorambucil supports mechanism-focused studies of DNA crosslinking, growth arrest, and cell killing across leukemia, glioma, endothelial, and mesenchymal models. This workflow pairs exposure control with orthogonal viability and apoptosis measurements so researchers can distinguish slowed proliferation from true cytotoxicity.
-
Genetic Toxicology of Glutaraldehyde: Evidence and Limits
2026-09-28
Vergnes and Ballantyne evaluated glutaraldehyde across bacterial mutation, mammalian-cell genotoxicity, and in vivo cytogenetic assays, finding a weak metabolic-activation-dependent response in one bacterial strain but no convincing mammalian or in vivo genotoxicity. The study’s integrated design shows why isolated positive results should be interpreted alongside gene mutation, chromosomal damage, micronucleus, and exposure-context data.
-
CFDA SE Cell Tracer Kit: Practical Workflow
2026-09-28
The CFDA SE Cell Tracer Kit provides covalent fluorescent labeling for following cell populations in proliferation assays, lineage tracing, and in vitro or in vivo tracking. It is suited to persistent labeling, but not to reversible marking or real-time measurement of cell behavior; signal dilution and cell-specific effects should be assessed in each workflow.
-
Gastric Cancer Assembloids Capture Tumor–Stroma Effects
2026-09-27
A patient-derived gastric cancer assembloid study integrates tumor organoids with stromal cell populations obtained from matched tumor tissue. The model reveals that stromal context can alter gene expression and drug sensitivity, supporting its use for investigating tumor–stroma interactions while underscoring the need for further validation.
-
Annexin V-Cy5 Apoptosis Kit for Microglia Studies
2026-09-26
Use the Annexin V-Cy5 Apoptosis Kit to test whether a stressed microglial population is undergoing apoptosis or showing a different cellular defect. Its rapid PS-based readout complements, but does not replace, lysosomal-function and phagocytosis assays in zebrafish and other research models.
-
Br-DAPI Workflows for Cardiac Lipotoxicity Studies
2026-09-25
Br-DAPI provides bright, selective nuclear labeling for live- or fixed-cell imaging in cardiac lipotoxicity workflows. Pair it with established viability, lipid, and ER-stress assays to distinguish changes in cell number from changes in injury-related biology.
-
LG 101506: Separating RXR and Tumor-Immune Signals
2026-09-25
Explore how LG 101506, an RXR modulator, can support carefully controlled nuclear receptor research. This article connects RXR assay design with findings on RBMS1 and PD-L1 while showing how to investigate the two systems without assuming an unproven mechanistic link.
-
Lovastatin Workflows for Cell Biology
2026-09-24
Use Lovastatin to probe how HMG-CoA reductase inhibition links mevalonate-pathway disruption with changes in proliferation, apoptosis, and macrophage clearance. This guide pairs practical dosing and handling advice with a careful distinction between mammalian cell experiments and findings from an Arabidopsis meristem study.
-
Praeruptorin A Dampens TLR3-Linked Inflammation in Macrophag
2026-09-24
In poly(I:C)-stimulated RAW264.7 macrophages, Praeruptorin A reduced inflammatory gene expression and inhibited NF-κB pathway activation. The study combines transcriptomic screening with targeted validation, providing evidence for an anti-inflammatory effect in a TLR3-agonist cell model while leaving its direct molecular targets and in vivo relevance unresolved.
-
iRhom2 in Olfaction: Odor-Driven Adaptation
2026-09-23
Azzopardi and colleagues identify iRhom2 as an olfactory sensory neuron-associated regulator linked to odor-dependent changes in olfactory receptor and activity-gene expression. Their findings support a candidate iRhom2–ADAM17 feedback mechanism, while leaving important questions about causality and the relevant ADAM17 substrates unresolved.
-
N1-Methyl-Pseudouridine-5'-Triphosphate Workflow
2026-09-23
Build more informative RNA experiments by pairing N1-Methyl-Pseudouridine-5'-Triphosphate with controlled transcription, translation, stability, and junction assays. This workflow also shows how lessons from retrotransposon insertion research can sharpen RNA-template quality control without overstating what the reference study proves.
-
CD80 mRNA: From Costimulation to Translation
2026-09-22
A mechanistic and strategic framework for using mouse CD80 mRNA to interrogate T-cell costimulation, validate causal biology, and design more disciplined translational studies without overstating preclinical evidence.